Quality of life evaluation in type 2 diabetic patients and sensitive deficit prevalence in lower extremity

• Autor(a) principal: Silva, Hengrid Graciely Nascimento
• Data de Publicação: 2017
• Outros Autores: Lopes, Renata Miranda de Araujo Laet, Feitosa, Maura Cristina Porto, Sousa, Karen de Freitas, Oliveira, Rauirys Alencar de
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Revista Brasileira de Qualidade de Vida
• Texto Completo: https://periodicos.utfpr.edu.br/rbqv/article/view/6033
• topic: 4.00.00.00-1 4.06.00.00-9; Qualidade de vida; Diabetes Mellitus; Pé diabético.; Quality of life; Diabetes mellitus; Diabetic foot.

OBJECTIVE: To evaluate and compare a quality of life and sensitivity of the feet of diabetic patients.METHODS: Quantitative cross-sectional study was performed with 40 patients with type 2 diabetes. The SF-36 questionnaire and Semmes-Weinstein monofilaments were used. The data were worked by number and percentage and the statistical test used was the Mann-Whitney U, which evaluated the degree of interlacing of the data of the two groups after the ordering, with a confidence interval of 95% and significance at p <0, 05.RESULTS: Of the 40 subjects, 62.5% were women, with a mean age of 57 ± 9.8 years. The body mass index was 26.4 ± 3.4 kg / m2 and the disease diagnosis time was 8.9 ± 7.7 years. It was observed that the emotional aspects (with and without mean sensitivity change of 52.0% and 87.5% respectively) and physical (with and without mean sensory change of 47.7% and 71.9%, respectively) were those that Presented a greater difference, although not statistically significant.CONCLUSIONS: The quality of life of patients unchanged sensitive were better compared to most domains: physical, social and emotional aspects, vitality and mental health with the exception of functional capacity, pain and general health where the quality of life of the two groups was equivalent. There is no change in quality of life compared to sensory impairment statistically significant, but it was found that in most domains of the SF-36 patients without sensory change had better quality of life.